QUALITY OF LIFE, TREATMENTS, AND PATIENTS' WILLINGNESS TO PAY FOR A COMPLETE REMISSION OF CERVICAL CANCER IN TAIWAN-Reference-Cited by-同舟云学术

QUALITY OF LIFE, TREATMENTS, AND PATIENTS' WILLINGNESS TO PAY FOR A COMPLETE REMISSION OF CERVICAL CANCER IN TAIWAN

Published:2011-09-09 Issue:10 Volume:21 Page:1217-1233
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Econ.

Author:

Lang Hui-Chu¹,Chang Koyin²,Ying Yung-Hsiang³

Affiliation:

1. Institute of Hospital and Health Care Administration; National Yang-Ming University; Taipei; Taiwan

2. Department of Healthcare Information and Management; Ming Chuan University; Taoyuan; Taiwan

3. Institute of Economics; National Sun Yat-sen University; Kaohsiung; Taiwan

Publisher

Wiley

Subject

Health Policy

Reference48 articles.

1. Cheap talk revisited: new evidence from CVM;Aadland;Journal of Economic Behavior & Organization,2006

2. American Cancer Society 2009 What Are the Key Statistics About Cervical Cancer? http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_cervical_cancer_8.asp

3. American Cancer Society 2011 How is cancer staged? http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_How_is_cervical_cancer_staged_8.asp

4. Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials;Anderson;British Journal of Cancer,1998

5. Annual Report of Bureau of Health Promotion Taiwan Department of Health 2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel;Israel Journal of Health Policy Research;2024-02-19

2. Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203;Gynecologic Oncology;2023-08

3. Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review;Expert Review of Pharmacoeconomics & Outcomes Research;2023-01-24

4. Determination of a cost-effectiveness threshold for cancer interventions in Iran;Frontiers in Oncology;2022-12-12

5. Innovation, Incentives, and Information Technology in the Healthcare Industry;Contributions to Economics;2022